Carret Asset Management’s China Pharma Holdings CPHI Stock Holding History

Carret Asset Management’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-60	Closed	-$10K	–	267
2013 Q4	$10K	Sell	60 -30	-33%	-$5.05K	﹤0.01%	263
2013 Q3	$13K	Hold	90	–	–	﹤0.01%	256
2013 Q2	$9K	Buy	+90	New	+$10.5K	﹤0.01%	317

Other funds holding CPHI

Pope Asset Management Memphis, Tennessee $162M AUM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Carret Asset Management's CPHI Position: Q1 2014 in Review

Carret Asset Management sold out of China Pharma Holdings (CPHI) in Q1 2014, closing a stake of 60 shares — an estimated $10K sold.

Carret Asset Management first reported a position in CPHI in Q2 2013 and held it in 3 quarters. The position peaked at $13K in Q3 2013. 7 funds tracked by Wall St. Rank hold CPHI as of Q1 2014.

Carret Asset Management reported no remaining China Pharma Holdings position as of Q1 2014 after selling out during the quarter.
Carret Asset Management sold 60 China Pharma Holdings shares in Q1 2014, an estimated $10K.
Carret Asset Management first reported a position in China Pharma Holdings in Q2 2013 and held it in 3 quarters.
Carret Asset Management's China Pharma Holdings position peaked at $13K in Q3 2013.
7 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2014.

Based on Carret Asset Management's 13F filing for Q1 2014, filed 15 May 2014.